0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vortioxetine Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-24S7624
Home | Market Reports | Health | Pharmacy | Drugs & Medications
Global Vortioxetine Market Insights and Forecast to 2028

Global Vortioxetine Market Insights and Forecast to 2028

Code: QYRE-Auto-24S7624
Report
May 2022
70 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Vortioxetine is an atypical antipsychotic and antidepressant indicated for the treatment of major depressive disorder (MDD). It is classified as a serotonin modulator and simulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotransmitter system whereby it simultaneously modulates one or more serotonin receptors and inhibits the reuptake of serotonin. More specifically, vortioxetine acts via the following biological mechanisms: as a serotonin reuptake inhibitor (SRI) through inhibition of the serotonin transporter, as a partial agonist of the 5-HT1B receptor, an agonist of 5-HT1A, and an antagonist of the 5-HT3, 5-HT1D, and 5-HT7 receptors. 
Market Analysis and Insights: Global Vortioxetine Market

Due to the COVID-19 pandemic, the global Vortioxetine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, 5 Mg Tablets accounting for % of the Vortioxetine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Depression segment is altered to an % CAGR throughout this forecast period.
China Vortioxetine market size is valued at US$ million in 2021, while the US and Europe Vortioxetine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Vortioxetine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Vortioxetine include Takeda, Lundbeck and CGeneTech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Vortioxetine Scope and Segment
Vortioxetine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Vortioxetine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

5 Mg Tablets
10 Mg Tablet
15 Mg Tablet
20 Mg Tablet

Segment by Application

Depression
Generalized Anxiety Disorder
Attention Deficit Hyperactivity Disorder
Other

BY COMPANY

Takeda
Lundbeck
CGeneTech

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Vortioxetine Product Introduction
1.2 Market by Type
1.2.1 Global Vortioxetine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 5 Mg Tablets
1.2.3 10 Mg Tablet
1.2.4 15 Mg Tablet
1.2.5 20 Mg Tablet
1.3 Market by Application
1.3.1 Global Vortioxetine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Depression
1.3.3 Generalized Anxiety Disorder
1.3.4 Attention Deficit Hyperactivity Disorder
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vortioxetine Sales Estimates and Forecasts 2017-2028
2.2 Global Vortioxetine Revenue Estimates and Forecasts 2017-2028
2.3 Global Vortioxetine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vortioxetine Sales by Region
2.4.1 Global Vortioxetine Sales by Region (2017-2022)
2.4.2 Global Sales Vortioxetine by Region (2023-2028)
2.5 Global Vortioxetine Revenue by Region
2.5.1 Global Vortioxetine Revenue by Region (2017-2022)
2.5.2 Global Vortioxetine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vortioxetine Sales by Manufacturers
3.1.1 Global Top Vortioxetine Manufacturers by Sales (2017-2022)
3.1.2 Global Vortioxetine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vortioxetine in 2021
3.2 Global Vortioxetine Revenue by Manufacturers
3.2.1 Global Vortioxetine Revenue by Manufacturers (2017-2022)
3.2.2 Global Vortioxetine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vortioxetine Revenue in 2021
3.3 Global Vortioxetine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vortioxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vortioxetine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vortioxetine Sales by Type
4.1.1 Global Vortioxetine Historical Sales by Type (2017-2022)
4.1.2 Global Vortioxetine Forecasted Sales by Type (2023-2028)
4.1.3 Global Vortioxetine Sales Market Share by Type (2017-2028)
4.2 Global Vortioxetine Revenue by Type
4.2.1 Global Vortioxetine Historical Revenue by Type (2017-2022)
4.2.2 Global Vortioxetine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vortioxetine Revenue Market Share by Type (2017-2028)
4.3 Global Vortioxetine Price by Type
4.3.1 Global Vortioxetine Price by Type (2017-2022)
4.3.2 Global Vortioxetine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vortioxetine Sales by Application
5.1.1 Global Vortioxetine Historical Sales by Application (2017-2022)
5.1.2 Global Vortioxetine Forecasted Sales by Application (2023-2028)
5.1.3 Global Vortioxetine Sales Market Share by Application (2017-2028)
5.2 Global Vortioxetine Revenue by Application
5.2.1 Global Vortioxetine Historical Revenue by Application (2017-2022)
5.2.2 Global Vortioxetine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vortioxetine Revenue Market Share by Application (2017-2028)
5.3 Global Vortioxetine Price by Application
5.3.1 Global Vortioxetine Price by Application (2017-2022)
5.3.2 Global Vortioxetine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vortioxetine Market Size by Type
6.1.1 North America Vortioxetine Sales by Type (2017-2028)
6.1.2 North America Vortioxetine Revenue by Type (2017-2028)
6.2 North America Vortioxetine Market Size by Application
6.2.1 North America Vortioxetine Sales by Application (2017-2028)
6.2.2 North America Vortioxetine Revenue by Application (2017-2028)
6.3 North America Vortioxetine Market Size by Country
6.3.1 North America Vortioxetine Sales by Country (2017-2028)
6.3.2 North America Vortioxetine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vortioxetine Market Size by Type
7.1.1 Europe Vortioxetine Sales by Type (2017-2028)
7.1.2 Europe Vortioxetine Revenue by Type (2017-2028)
7.2 Europe Vortioxetine Market Size by Application
7.2.1 Europe Vortioxetine Sales by Application (2017-2028)
7.2.2 Europe Vortioxetine Revenue by Application (2017-2028)
7.3 Europe Vortioxetine Market Size by Country
7.3.1 Europe Vortioxetine Sales by Country (2017-2028)
7.3.2 Europe Vortioxetine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vortioxetine Market Size by Type
8.1.1 Asia Pacific Vortioxetine Sales by Type (2017-2028)
8.1.2 Asia Pacific Vortioxetine Revenue by Type (2017-2028)
8.2 Asia Pacific Vortioxetine Market Size by Application
8.2.1 Asia Pacific Vortioxetine Sales by Application (2017-2028)
8.2.2 Asia Pacific Vortioxetine Revenue by Application (2017-2028)
8.3 Asia Pacific Vortioxetine Market Size by Region
8.3.1 Asia Pacific Vortioxetine Sales by Region (2017-2028)
8.3.2 Asia Pacific Vortioxetine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vortioxetine Market Size by Type
9.1.1 Latin America Vortioxetine Sales by Type (2017-2028)
9.1.2 Latin America Vortioxetine Revenue by Type (2017-2028)
9.2 Latin America Vortioxetine Market Size by Application
9.2.1 Latin America Vortioxetine Sales by Application (2017-2028)
9.2.2 Latin America Vortioxetine Revenue by Application (2017-2028)
9.3 Latin America Vortioxetine Market Size by Country
9.3.1 Latin America Vortioxetine Sales by Country (2017-2028)
9.3.2 Latin America Vortioxetine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vortioxetine Market Size by Type
10.1.1 Middle East and Africa Vortioxetine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vortioxetine Revenue by Type (2017-2028)
10.2 Middle East and Africa Vortioxetine Market Size by Application
10.2.1 Middle East and Africa Vortioxetine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vortioxetine Revenue by Application (2017-2028)
10.3 Middle East and Africa Vortioxetine Market Size by Country
10.3.1 Middle East and Africa Vortioxetine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vortioxetine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Overview
11.1.3 Takeda Vortioxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Takeda Vortioxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Lundbeck
11.2.1 Lundbeck Corporation Information
11.2.2 Lundbeck Overview
11.2.3 Lundbeck Vortioxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Lundbeck Vortioxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lundbeck Recent Developments
11.3 CGeneTech
11.3.1 CGeneTech Corporation Information
11.3.2 CGeneTech Overview
11.3.3 CGeneTech Vortioxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CGeneTech Vortioxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CGeneTech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vortioxetine Industry Chain Analysis
12.2 Vortioxetine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vortioxetine Production Mode & Process
12.4 Vortioxetine Sales and Marketing
12.4.1 Vortioxetine Sales Channels
12.4.2 Vortioxetine Distributors
12.5 Vortioxetine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vortioxetine Industry Trends
13.2 Vortioxetine Market Drivers
13.3 Vortioxetine Market Challenges
13.4 Vortioxetine Market Restraints
14 Key Findings in The Global Vortioxetine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Vortioxetine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 5 Mg Tablets
    Table 3. Major Manufacturers of 10 Mg Tablet
    Table 4. Major Manufacturers of 15 Mg Tablet
    Table 5. Major Manufacturers of 20 Mg Tablet
    Table 6. Global Vortioxetine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Vortioxetine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Vortioxetine Sales by Region (2017-2022) & (M Pcs)
    Table 9. Global Vortioxetine Sales Market Share by Region (2017-2022)
    Table 10. Global Vortioxetine Sales by Region (2023-2028) & (M Pcs)
    Table 11. Global Vortioxetine Sales Market Share by Region (2023-2028)
    Table 12. Global Vortioxetine Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Vortioxetine Revenue Market Share by Region (2017-2022)
    Table 14. Global Vortioxetine Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Vortioxetine Revenue Market Share by Region (2023-2028)
    Table 16. Global Vortioxetine Sales by Manufacturers (2017-2022) & (M Pcs)
    Table 17. Global Vortioxetine Sales Share by Manufacturers (2017-2022)
    Table 18. Global Vortioxetine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Vortioxetine Revenue Share by Manufacturers (2017-2022)
    Table 20. Vortioxetine Price by Manufacturers (2017-2022) &(US$/Pcs)
    Table 21. Global Vortioxetine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Vortioxetine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vortioxetine as of 2021)
    Table 23. Vortioxetine Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Vortioxetine Product Offered
    Table 25. Date of Manufacturers Enter into Vortioxetine Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Vortioxetine Sales by Type (2017-2022) & (M Pcs)
    Table 28. Global Vortioxetine Sales by Type (2023-2028) & (M Pcs)
    Table 29. Global Vortioxetine Sales Share by Type (2017-2022)
    Table 30. Global Vortioxetine Sales Share by Type (2023-2028)
    Table 31. Global Vortioxetine Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Vortioxetine Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Vortioxetine Revenue Share by Type (2017-2022)
    Table 34. Global Vortioxetine Revenue Share by Type (2023-2028)
    Table 35. Vortioxetine Price by Type (2017-2022) & (US$/Pcs)
    Table 36. Global Vortioxetine Price Forecast by Type (2023-2028) & (US$/Pcs)
    Table 37. Global Vortioxetine Sales by Application (2017-2022) & (M Pcs)
    Table 38. Global Vortioxetine Sales by Application (2023-2028) & (M Pcs)
    Table 39. Global Vortioxetine Sales Share by Application (2017-2022)
    Table 40. Global Vortioxetine Sales Share by Application (2023-2028)
    Table 41. Global Vortioxetine Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Vortioxetine Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Vortioxetine Revenue Share by Application (2017-2022)
    Table 44. Global Vortioxetine Revenue Share by Application (2023-2028)
    Table 45. Vortioxetine Price by Application (2017-2022) & (US$/Pcs)
    Table 46. Global Vortioxetine Price Forecast by Application (2023-2028) & (US$/Pcs)
    Table 47. North America Vortioxetine Sales by Type (2017-2022) & (M Pcs)
    Table 48. North America Vortioxetine Sales by Type (2023-2028) & (M Pcs)
    Table 49. North America Vortioxetine Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Vortioxetine Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Vortioxetine Sales by Application (2017-2022) & (M Pcs)
    Table 52. North America Vortioxetine Sales by Application (2023-2028) & (M Pcs)
    Table 53. North America Vortioxetine Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Vortioxetine Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Vortioxetine Sales by Country (2017-2022) & (M Pcs)
    Table 56. North America Vortioxetine Sales by Country (2023-2028) & (M Pcs)
    Table 57. North America Vortioxetine Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Vortioxetine Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Vortioxetine Sales by Type (2017-2022) & (M Pcs)
    Table 60. Europe Vortioxetine Sales by Type (2023-2028) & (M Pcs)
    Table 61. Europe Vortioxetine Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Vortioxetine Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Vortioxetine Sales by Application (2017-2022) & (M Pcs)
    Table 64. Europe Vortioxetine Sales by Application (2023-2028) & (M Pcs)
    Table 65. Europe Vortioxetine Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Vortioxetine Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Vortioxetine Sales by Country (2017-2022) & (M Pcs)
    Table 68. Europe Vortioxetine Sales by Country (2023-2028) & (M Pcs)
    Table 69. Europe Vortioxetine Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Vortioxetine Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Vortioxetine Sales by Type (2017-2022) & (M Pcs)
    Table 72. Asia Pacific Vortioxetine Sales by Type (2023-2028) & (M Pcs)
    Table 73. Asia Pacific Vortioxetine Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Vortioxetine Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Vortioxetine Sales by Application (2017-2022) & (M Pcs)
    Table 76. Asia Pacific Vortioxetine Sales by Application (2023-2028) & (M Pcs)
    Table 77. Asia Pacific Vortioxetine Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Vortioxetine Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Vortioxetine Sales by Region (2017-2022) & (M Pcs)
    Table 80. Asia Pacific Vortioxetine Sales by Region (2023-2028) & (M Pcs)
    Table 81. Asia Pacific Vortioxetine Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Vortioxetine Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Vortioxetine Sales by Type (2017-2022) & (M Pcs)
    Table 84. Latin America Vortioxetine Sales by Type (2023-2028) & (M Pcs)
    Table 85. Latin America Vortioxetine Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Vortioxetine Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Vortioxetine Sales by Application (2017-2022) & (M Pcs)
    Table 88. Latin America Vortioxetine Sales by Application (2023-2028) & (M Pcs)
    Table 89. Latin America Vortioxetine Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Vortioxetine Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Vortioxetine Sales by Country (2017-2022) & (M Pcs)
    Table 92. Latin America Vortioxetine Sales by Country (2023-2028) & (M Pcs)
    Table 93. Latin America Vortioxetine Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Vortioxetine Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Vortioxetine Sales by Type (2017-2022) & (M Pcs)
    Table 96. Middle East and Africa Vortioxetine Sales by Type (2023-2028) & (M Pcs)
    Table 97. Middle East and Africa Vortioxetine Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Vortioxetine Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Vortioxetine Sales by Application (2017-2022) & (M Pcs)
    Table 100. Middle East and Africa Vortioxetine Sales by Application (2023-2028) & (M Pcs)
    Table 101. Middle East and Africa Vortioxetine Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Vortioxetine Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Vortioxetine Sales by Country (2017-2022) & (M Pcs)
    Table 104. Middle East and Africa Vortioxetine Sales by Country (2023-2028) & (M Pcs)
    Table 105. Middle East and Africa Vortioxetine Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Vortioxetine Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Takeda Corporation Information
    Table 108. Takeda Description and Major Businesses
    Table 109. Takeda Vortioxetine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 110. Takeda Vortioxetine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Takeda Recent Developments
    Table 112. Lundbeck Corporation Information
    Table 113. Lundbeck Description and Major Businesses
    Table 114. Lundbeck Vortioxetine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 115. Lundbeck Vortioxetine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Lundbeck Recent Developments
    Table 117. CGeneTech Corporation Information
    Table 118. CGeneTech Description and Major Businesses
    Table 119. CGeneTech Vortioxetine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 120. CGeneTech Vortioxetine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. CGeneTech Recent Developments
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Vortioxetine Distributors List
    Table 125. Vortioxetine Customers List
    Table 126. Vortioxetine Market Trends
    Table 127. Vortioxetine Market Drivers
    Table 128. Vortioxetine Market Challenges
    Table 129. Vortioxetine Market Restraints
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vortioxetine Product Picture
    Figure 3. Global Vortioxetine Market Share by Type in 2021 & 2028
    Figure 3. 5 Mg Tablets Product Picture
    Figure 4. 10 Mg Tablet Product Picture
    Figure 5. 15 Mg Tablet Product Picture
    Figure 6. 20 Mg Tablet Product Picture
    Figure 7. Global Vortioxetine Market Share by Application in 2021 & 2028
    Figure 8. Depression
    Figure 9. Generalized Anxiety Disorder
    Figure 10. Attention Deficit Hyperactivity Disorder
    Figure 11. Other
    Figure 12. Vortioxetine Report Years Considered
    Figure 13. Global Vortioxetine Sales 2017-2028 (M Pcs)
    Figure 14. Global Vortioxetine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Vortioxetine Revenue 2017-2028 (US$ Million)
    Figure 16. Global Vortioxetine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Vortioxetine Sales Market Share by Region (2017-2022)
    Figure 18. Global Vortioxetine Sales Market Share by Region (2023-2028)
    Figure 19. North America Vortioxetine Sales YoY (2017-2028) & (M Pcs)
    Figure 20. North America Vortioxetine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Vortioxetine Sales YoY (2017-2028) & (M Pcs)
    Figure 22. Europe Vortioxetine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Vortioxetine Sales YoY (2017-2028) & (M Pcs)
    Figure 24. Asia-Pacific Vortioxetine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Vortioxetine Sales YoY (2017-2028) & (M Pcs)
    Figure 26. Latin America Vortioxetine Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Vortioxetine Sales YoY (2017-2028) & (M Pcs)
    Figure 28. Middle East & Africa Vortioxetine Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Vortioxetine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Vortioxetine in the World: Market Share by Vortioxetine Revenue in 2021
    Figure 31. Global Vortioxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Vortioxetine Sales Market Share by Type (2017-2028)
    Figure 33. Global Vortioxetine Revenue Market Share by Type (2017-2028)
    Figure 34. Global Vortioxetine Sales Market Share by Application (2017-2028)
    Figure 35. Global Vortioxetine Revenue Market Share by Application (2017-2028)
    Figure 36. North America Vortioxetine Sales Market Share by Type (2017-2028)
    Figure 37. North America Vortioxetine Revenue Market Share by Type (2017-2028)
    Figure 38. North America Vortioxetine Sales Market Share by Application (2017-2028)
    Figure 39. North America Vortioxetine Revenue Market Share by Application (2017-2028)
    Figure 40. North America Vortioxetine Sales Share by Country (2017-2028)
    Figure 41. North America Vortioxetine Revenue Share by Country (2017-2028)
    Figure 42. U.S. Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Vortioxetine Sales Market Share by Type (2017-2028)
    Figure 45. Europe Vortioxetine Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Vortioxetine Sales Market Share by Application (2017-2028)
    Figure 47. Europe Vortioxetine Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Vortioxetine Sales Share by Country (2017-2028)
    Figure 49. Europe Vortioxetine Revenue Share by Country (2017-2028)
    Figure 50. Germany Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 51. France Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Vortioxetine Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Vortioxetine Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Vortioxetine Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Vortioxetine Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Vortioxetine Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Vortioxetine Revenue Share by Region (2017-2028)
    Figure 61. China Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 64. India Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Vortioxetine Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Vortioxetine Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Vortioxetine Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Vortioxetine Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Vortioxetine Sales Share by Country (2017-2028)
    Figure 76. Latin America Vortioxetine Revenue Share by Country (2017-2028)
    Figure 77. Mexico Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Vortioxetine Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Vortioxetine Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Vortioxetine Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Vortioxetine Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Vortioxetine Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Vortioxetine Revenue Share by Country (2017-2028)
    Figure 86. Turkey Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Vortioxetine Revenue (2017-2028) & (US$ Million)
    Figure 89. Vortioxetine Value Chain
    Figure 90. Vortioxetine Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global and United States Low dosage Hydrate Inhibitors Market Report Forecast 2022 2028
Global and United States Low dosage Hydrate Inhibitors Market Report & Forecast 2022-2028

Low dosage hydrate inhibitors are chemicals that help manage flow without the huge volume of chemicals that are required for thermodynamic inhibition.Market Analysis and Insights Global and United States Low dosage Hydrate Inhibitors MarketThis report focuses on global and United States Low dosage Hydrate Inhibitors market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Low dosage Hydrate Inhibitors market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-8W10686
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Drug Infusion Systems Market Report Forecast 2022 2028
Global and United States Drug Infusion Systems Market Report & Forecast 2022-2028

The drug infusion systems market includes various infusion systems products including the components such as pumps accessories and disposables.Market Analysis and Insights Global and United States Drug Infusion Systems MarketThis report focuses on global and United States Drug Infusion Systems market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Drug Infusion Systems market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-6M10719
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Insulin Drug Delivery Devices Market Report Forecast 2022 2028
Global and United States Insulin Drug Delivery Devices Market Report & Forecast 2022-2028

Insulin delivery devices that are currently available for the administration of insulin include syringes insulin infusion pumps jet injectors and pens.Market Analysis and Insights Global and United States Insulin Drug Delivery Devices MarketThis report focuses on global and United States Insulin Drug Delivery Devices market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Insulin Drug Delivery Devices market size is estimated to be worth US 14710 million in 2022 and is forecast to a readjusted size of US 19310 million by 2028 with a CAGR of 4.6 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-37X10341
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Stroke Treatment Drugs Market Report Forecast 2022 2028
Global and United States Stroke Treatment Drugs Market Report & Forecast 2022-2028

Stroke is a disruption in brain function caused by lack of blood flow to the brain.Market Analysis and Insights Global and United States Stroke Treatment Drugs MarketThis report focuses on global and United States Stroke Treatment Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Stroke Treatment Drugs market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-27B10301
Tue Jun 07 00:00:00 UTC 2022

Add to Cart